OMNICELL INC (OMCL) Stock News
NASDAQ:OMCL - Nasdaq - US68213N1090 - Common Stock - Currency: USD
OMCL Latest News, Press Relases and Analysis
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and the rest of the healthcare technology for providers stocks fared in Q4.
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and worst performers in the healthcare technology for providers industry.
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025
Omnicell Catapults And Breaks Out After Obliterating Profit Expectations
The company makes software the manages medication dispensing.
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Omnicell Announces Chief Financial Officer Transition
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.
Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results
Earnings To Watch: Omnicell (OMCL) Reports Q4 Results Tomorrow
Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect.
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Omnicell Announces OmniSphere
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes
